SCHEMBL3602746

SCHEMBL3602746

CCOC(=O)c1c(-c2ccccc2C)[nH]c2c1CCc1cnccc1-2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.47
PTGES O14684 3/20 0.47
MAPT P10636 5/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.41
NPC1 O15118 1/20 0.41
TDP2 O95551 1/20 0.41
NSD2 O96028 1/20 0.41
THRB P10828 1/20 0.41
XBP1 P17861 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
GALK1 P51570 1/20 0.41
BLM P54132 1/20 0.41
PAX8 Q06710 1/20 0.41
ATM Q13315 1/20 0.41
TSHR P16473 1/20 0.41
KDM5A P29375 1/20 0.40
KDM5B Q9UGL1 1/20 0.40
KDM4E B2RXH2 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3599326 0.90 ALDH1A1 (0.43) MAPTSMN1; SMN2LMNANPC1TDP2
SCHEMBL3593137 0.83 KDM5A (0.42) ALOX5PTGESMAPTSMN1; SMN2LMNA
Bromide SCHEMBL3593135 0.82 KDM5A (0.42) ALOX5PTGESMAPTSMN1; SMN2LMNA
SCHEMBL3597842 0.81 CDK4 (0.39) ALOX5PTGESMAPTSMN1; SMN2LMNA
SCHEMBL3609436 0.79 ALOX5 (0.44) ALOX5PTGESMAPTSMN1; SMN2LMNA
SCHEMBL3599880 0.75 KDM4E (0.42) MAPTTSHRKDM5AKDM5BKDM4E
SCHEMBL4441274 0.73 ALOX5 (0.46) ALOX5PTGESMAPTSMN1; SMN2LMNA
SCHEMBL3590440 0.72 APAF1 (0.39) MAPTTSHRKDM5AKDM5BKDM4E
SCHEMBL15005768 0.71 CCNC (0.34) MAPTKDM5AKDM5BKDM4EALDH1A1
SCHEMBL6794908 0.70 AURKA (0.54) MAPTSMN1; SMN2LMNANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118102-B1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES SRL (IT) 2013-06-12 EP disclosed
US-8207180-B2 Tricyclic indoles and (4,5-dihydro) indoles NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-26 US disclosed
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES CDC7, CDK7, CDK17 ALOX5 4088/4885PTGES 4613/4885MAPT 2291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.